Loading HEALTHX price...
Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 7 Aug 2026), sales rose 49.7% from a year earlier to Rs 447 cr and profit fell 92.5% to Rs 2.0 cr.
- Reported a loss in FY25 and FY26.
- Profit before interest covered interest -2.0 times in FY26 (Rs 1 cr of interest).
- Return on equity stayed under 10% from FY24 to FY26 (highest 0.6%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 20 results, the share rose on 6 and fell on 14, and moved by 3% or more on 9.
Q1 FY27: results filed 7 Aug 2026. The share went from its close on 6 Aug 2026 to its close on 10 Aug 2026 -1.85%.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | -11.4% | 0.6% | -15.5% | -0.2% |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 936 Cr of assets. Its owners funded 82% of that, with no borrowings.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business moved Rs -74 Cr through operations; for a lender that is mostly loans made and deposits taken, not trading cash.
Full financial year to 2026-03-31, from the company's cash flow statement. This company lends for a living: money lent out is an operating outflow, so these are not coloured as good or bad.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| LALPATHLAB Dr. Lal Path Labs Ltd. | 31,100 cr | 44.8x | 12.4x | 21.5% | 25.7% | 0.00 | 18.9% | +19.1% | 0.72% |
| VIJAYA Vijaya Diagnostic Centre Limited | 14,362 cr | 76.7x | 15.0x | 19.6% | 19.2% | 0.00 | 21.9% | +22.8% | 0.14% |
| METROPOLIS Metropolis Healthcare Limited | 10,989 cr | 22.8x | 7.3x | 13.3% | 15.7% | 0.01 | 11.9% | +16.6% | 0.19% |
| THYROCARE Thyrocare Technologies Limited | 7,491 cr | 27.6x | 12.8x | 30.0% | 33.6% | 0.00 | 20.1% | +24.3% | 1.98% |
| NEPHROPLUS Nephrocare Health Services Limited | 6,095 cr | - | 5.5x | - | 13.7% | 0.07 | - | - | 0.00% |
| SURAKSHA Suraksha Diagnostic Limited | 1,628 cr | 45.4x | 6.7x | 14.4% | 14.7% | 0.01 | 10.8% | +20.8% | 0.00% |
| KRSNAA Krsnaa Diagnostics Limited | 1,617 cr | 16.8x | 1.6x | 9.9% | 10.6% | 0.55 | 11.9% | +22.1% | 0.55% |
| HEALTHX Health X Platform Limited | 857 cr | - | 1.3x | -3.4% | - | - | -1.8% | +49.7% | 0.00% |
| GAUDIUMIVF Gaudium IVF and Women Health Limited | 674 cr | - | 4.4x | - | 23.1% | 0.15 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from -6.1% to -3.9% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.